Page last updated: 2024-08-25

homoeriodictyol and cytochrome c-t

homoeriodictyol has been researched along with cytochrome c-t in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, AL; Li, HZ; Li, YR; Ren, DM; Shen, T; Wang, XN	1

Other Studies

1 other study(ies) available for homoeriodictyol and cytochrome c-t

Article	Year
Homoeriodictyol protects human endothelial cells against oxidative insults through activation of Nrf2 and inhibition of mitochondrial dysfunction. Vascular pharmacology, 2018, Volume: 109 Topics: Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Cytochromes c; Cytoprotection; Dose-Response Relationship, Drug; Flavones; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitochondria; NF-E2-Related Factor 2; Oxidants; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Time Factors	2018

Article

Year

Homoeriodictyol protects human endothelial cells against oxidative insults through activation of Nrf2 and inhibition of mitochondrial dysfunction.

Vascular pharmacology, 2018, Volume: 109

Topics: Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Cytochromes c; Cytoprotection; Dose-Response Relationship, Drug; Flavones; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitochondria; NF-E2-Related Factor 2; Oxidants; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Time Factors

2018